-- Pharmstandard Falls to 3-Year Low as UralSib Cuts Estimate
-- B y   K s e n i a   G a l o u c h k o
-- 2012-06-06T15:47:24Z
-- http://www.bloomberg.com/news/2012-06-06/pharmstandard-falls-to-3-year-low-as-uralsib-cuts-estimate-1-.html
OAO Pharmstandard (PHST)  fell to a three-
year low in  London  after Uralsib Capital cut its price estimate
following a decline in first-quarter revenue.  Pharmstandardâ€™s global depositary receipts lost 2.4 percent
to $12.80 as of 4:27 p.m. in London, the lowest level since June
2009. The GDRs fell as much as 20 percent to $10.51 earlier.  Uralsib cut its 2012 price estimate 13 percent to $21,
according to an e-mailed note. First-quarter revenue fell 31
percent to 2.93 billion rubles ($90 million) from a year
earlier, the company said on May 16.  To contact the reporter on this story:
Ksenia Galouchko in Moscow at 
 kgalouchko1@bloomberg.net ;  To contact the editor responsible for this story:
Gavin Serkin at 
 gserkin@bloomberg.net  